MAY 08, 2018 06:47 PM PDT

Promising Treatment for Alcoholism

WRITTEN BY: Nouran Amin

Investigators at the University of Texas at Austin have successfully used animal models to examine a drug believed to inhibit the symptoms of alcohol withdrawal, ultimately treating alcoholism.

Alcoholism is a chronic disease affecting more than 15 million Americans and many more across the globe. More specifically, it is a disease characterized by the preoccupation of alcohol. Although there exists an array of drugs to combat alcohol addiction, they are not always effective and tend to have negative side effects.

Now, the drug believed to treat alcohol addiction known as JVW-1034, was studied to work in worms and rats that exhibited symptoms of alcohol addiction. These results can eventually be illustrated in human patients with little to no side effects. However, UT-Austin researchers noted that the drug will need to go through intensive monitoring before any clinical trials on humans can occur.

JVW-1034 is unique because it works to inhibit an unconventional molecular pathway that produces no side effects. “There’s clearly a huge need for something different and better,” explains UT Austin researchers and co-author of the study, James Sahn. “That’s where our approach shines. It’s modulating a pathway that doesn’t seem to be associated with any of the other drugs that are available.”

Although JVW-1034 is promising, researchers are hoping to optimize the efficacy of the drugs chemical properties. They are planning to create a pill that can someday be able to block alcohol withdrawal symptoms and alcohol cravings in order to help affected individuals avoid relapse. Unfortunately, a creation of such pill is still unclear in its promise to treat alcoholism. This is primarily because alcoholism is a complex disease with a multitude of factors that may contribute to its pathophysiology. Regardless, a drug taken for a chronic disease can still be effective in treating stress and being beneficial for individuals affected by alcoholism.

“If we could achieve a medication that is effective for more people and doesn’t have the negative side effects that some of these drugs have, that would be game-changing,” says Stephen Martin, professor of chemistry at UT Austin and senior author.

Sources: University of Texas at Austin, Neuropsychopharmacology

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Does TruBrain Really Work?
TruBrain is a mix of different substances claimed to help people increase verbal fluency, avoid distractions, and boost their mental output. Created by a t...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Can Lifestyle Changes Switch Off Dementia Genes?
Around 50 million people have dementia worldwide, with 10 million new cases emerging each year (World Health Organization: 2019). Most prominent in people ...
OCT 14, 2019
Technology
OCT 14, 2019
Biomagents for Drug Discovery
Scientists have recently developed a chip-like device that utilizes tiny magnets that sort large populations of mixed cell types. "We casually agreed...
OCT 14, 2019
Drug Discovery & Development
OCT 14, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
OCT 14, 2019
Genetics & Genomics
OCT 14, 2019
Gene-Editing Breakthrough for Cervical Cancer
Researchers at the The Menzies Health Institute Queensland have found a way to use gene therapy CRISPR-Cas9 to treat cervical cancer. The first treatment o...
Loading Comments...